Correlation Between Veracyte and Terns Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Veracyte and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Veracyte and Terns Pharmaceuticals, you can compare the effects of market volatilities on Veracyte and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Terns Pharmaceuticals.

Diversification Opportunities for Veracyte and Terns Pharmaceuticals

-0.55

Correlation Coefficient

Veracyte  Terns Pharmaceuticals

Excellent diversification

The 3 months correlation between Veracyte and Terns is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Veracyte i.e., Veracyte and Terns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Veracyte and Terns Pharmaceuticals

Given the investment horizon of 90 days Veracyte is expected to generate 0.53 times more return on investment than Terns Pharmaceuticals. However, Veracyte is 1.87 times less risky than Terns Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  3,029  in Veracyte on August 31, 2024 and sell it today you would earn a total of  1,260  from holding Veracyte or generate 41.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Veracyte  vs.  Terns Pharmaceuticals

Veracyte

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.

Terns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Terns Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Veracyte and Terns Pharmaceuticals

The main advantage of trading using opposite Veracyte and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.

The idea behind Veracyte and Terns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.